Krystal Biotech Stock Quote KRYS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

198.405

Bid

192.72

Ask

288.00

Volume

397,781

193.445 Day's Range 200.73

93.95 52 Week Range 200.73

Market Cap

5.524B

Previous Close

193.42

Open

197.64

Last Trade

106

198.405

(priorref)

Last Trade Time

Financial Volume

$ 78,545,061

VWAP

197.4581

Average Volume (3m)

395,648

Shares Outstanding

28,558,440

Dividend Yield

PE Ratio

517.95

Earnings Per Share (EPS)

0.38

Revenue

50.7M

Net Profit

10.93M

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments... Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.krystalbio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Krystal Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KRYS. The last closing price for Krystal Biotech was $193.42. Over the last year, Krystal Biotech shares have traded in a share price range of $ 93.95 to $ 200.73.

Krystal Biotech currently has 28,558,440 shares outstanding. The market capitalization of Krystal Biotech is $5.52 billion. Krystal Biotech has a price to earnings ratio (PE ratio) of 517.95.

Overall Flow

Bearish

Net Premium

-616k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	22.405	12.7301136364	176	200.73	176	277807	190.7937367	CS
4	17.065	9.41049961398	181.34	200.73	168.41	609227	178.04650201	CS
12	30.435	18.1193070191	167.97	200.73	144.0001	395648	171.00896029	CS
26	71.555	56.409144659	126.85	200.73	107.5	392522	160.04452701	CS
52	75.545	61.4886863096	122.86	200.73	93.95	338812	140.67657344	CS
156	129.405	187.543478261	69	200.73	38.8563	262651	103.81824525	CS
260	154.055	347.361894025	44.35	200.73	31.89	218034	89.61242913	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LCFYLocafy Ltd	$ 6.10 (162.92%)	46.08M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	215.06M
CYNCYNGN Inc	$ 7.20 (81.82%)	17.89M
NEXINexImmune Inc	$ 3.84 (66.23%)	34.48M
BDRXBiodexa Pharmaceuticals PLC	$ 1.08 (51.88%)	59.99M
CETUUCetus Capital Acquisition Corporation	$ 7.00 (-29.72%)	1.42k
TRIBTrinity Biotech PLC	$ 2.046 (-28.96%)	81.02k
CINGCingulate Inc	$ 0.4845 (-25.23%)	1.33M
IVPInspire Veterinary Partners Inc	$ 5.5842 (-24.54%)	2.35M
SLRXSalarius Pharmaceuticals Inc	$ 2.12 (-22.70%)	1.99M
NVDANVIDIA Corporation	$ 127.40 (-5.57%)	374.79M
MAXNMaxeon Solar Technologies Ltd	$ 0.24 (13.85%)	355.59M
KZIAKazia Therapeutics Ltd	$ 1.24 (85.57%)	226.74M
TSLATesla Inc	$ 241.03 (-8.44%)	221.7M
SQQQProShares UltraPro Short QQQ	$ 7.63 (6.42%)	183.24M